The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
The Organoid Cell Atlas
Open accessAbstract
To the Editor — Human organoids hold tremendous potential for biomedical applications 1 , 2 , 3 (Fig. 1a,b ). These three-dimensional structures of cultured cells recapitulate important aspects of in vivo organ development and biological function. They provide tractable in vitro models of human physiology and pathology, thereby enabling interventional studies that are difficult or impossible to conduct in human subjects. For example, organoids allow genetic and pharmacological manipulation in a complex cellular context that reflects human biology, and they enable investigations of the early stages of organ development and disease onset. Human organoids complement (and may eventually replace) animal models in many areas of preclinical drug development. Moreover, they provide patient-specific ‘avatars’ for drug development and precision therapies, including treatments for cancer, rare genetic diseases (such as cystic fibrosis) and complex multifactorial disorders (such as epilepsy). Finally, they promise to contribute to regenerative medicine, with the goal of producing functional biological structures that can be transplanted into patients. Fig. 1: Combining organoids and single-cell technology for biomedical discovery and regenerative therapy. a , Organoids can be derived from adult stem cells, which are already committed to a specific cell lineage, tissue and/or organ, or from pluripotent cells, which can give rise to a broad set of cell types but requires more complex differentiation protocols. b , Human organoids are broadly useful for in vitro modeling of biological functions, drug testing and regenerative medicine. c , Key challenges for advancing organoid research include characterization and validation of organoids, development of new organoid protocols, and applications of organoids in basic biology and biomedical research. d , Single-cell technologies promise to advance organoid research by enabling systematic validation of the derived organoids, by informing organoid protocol development, and by providing a high-resolution readout for functional perturbation experiments in human organoids. Full size image
Overview
CoChat Summary
TL;DR
The paper announces the Organoid Cell Atlas, an open collaborative network within the Human Cell Atlas, and its EU H2020-funded HCA|Organoid pilot project. It argues that combining human organoids with single-cell and spatial profiling can improve organoid validation, protocol development, and functional perturbation studies.
Key findings
- The Organoid Cell Atlas is launched as an HCA Biological Network with four complementary directions: standardize single-cell profiling of human organoids, facilitate access to organoid data via HCA infrastructure, establish computational methods connecting organoid profiles with primary tissue data, and contextualize organoids using HCA profiles of their in vivo counterparts.
- The EU H2020 HCA|Organoid pilot will generate single-cell transcriptome profiles, epigenome maps, and detailed imaging data in selected human organoids; for colon and brain, it will derive and characterize organoids from 100 whole-genome-sequenced individuals each.
- The Organoid Cell Atlas Portal will build on the HCA Data Coordination Platform and provide interactive exploration, data-driven selection of organoids for functional experiments, comparison of disease-specific organoids against normal references, and cell–cell alignments between organoid and primary tissue profiles.
- Disease-centric pilot studies will include CRISPR screening with single-cell transcriptome readout (CROP-seq) and disease modeling of genetic epilepsy using brain organoids selected from the atlas; an initial version is planned within two years.
Methods
- This is a correspondence/perspective piece, not a primary research study; it describes a planned consortium, data infrastructure, and pilot project rather than reporting completed experiments or results.
- Planned data generation includes single-cell transcriptome profiles, epigenome maps, and detailed imaging in human organoids, with colon and brain organoids derived from 100 whole-genome-sequenced individuals each; colon organoids come from adult stem cells and brain organoids from pluripotent cells.
- Planned analyses include standardization and validation of organoid workflows, community metadata standards, computational alignment and comparison of cells between organoids and corresponding primary tissues, and interactive visualization for quality control and exploratory analysis.
Limitations
- The paper states that current organoid protocols may not faithfully represent the diversity of cell types in primary tissue, including non-parenchymal cells such as immune cells and stroma, and are limited in accounting for environmental exposures and organismal aging; it calls for robust protocols yielding adequate tissue organization, differentiated cells, vascularization, immune cell infiltration, and, for some organs, a microbiome.
- The paper states that better characterization and validation are needed, including extensive replication to quantify technical and biological variation and inclusion of genetically diverse donors to assess interindividual variation.
- Evident from the text: this is a proposal and pilot announcement with no empirical results or completed atlas; the initial version is planned within two years, and extensive further work is said to be needed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
1 Valid · 0 Not valid · 1 Not checked · 13 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These initial reports identified striking parallels among organoid development, human primary tissue and in vivo organogenesis”
§ The Organoid Cell Atlas > The Organoid Cell Atlas within the HCA
What the sources say
- Not checked yetcites [8] Grün, D. et al. Nature 525, 251–255 (2015). source
- Not checked yetcites [9] Camp, J. G. et al. Proc. Natl Acad. Sci. USA 112, 15672–15677 (2015). source
- Supportedcites [10] Quadrato, G. et al. Nature 545, 48–53 (2017). source
The Discussion (page unavailable) says organoid cells are closely related to their endogenous counterparts in the brain and retina. The section on protracted development (page unavailable) also reports that cell types emerged in an order resembling the endogenous developmental sequence. Together, these support the claimed parallels between organoid development and human brain tissue and development in vivo. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Human organoids complement (and may eventually replace) animal models in many areas of preclinical drug development.”
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, they provide patient-specific ‘avatars’ for drug development and precision therapies, including treatments for cancer, rare genetic diseases (such as cystic fibrosis) and complex multifactorial disorders (such as epilepsy).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Current organoid protocols, while useful for many applications, have relevant technical and conceptual limitations.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
None of the sources cited for this claim have been checked yet.
In the paper
“These three-dimensional structures of cultured cells recapitulate important aspects of in vivo organ development and biological function.”
What the sources say
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
5 more claims
Create a free account to see all 15 claims and to verify the 5 references still open.
- It may state two separate claims as one. 2
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Here, the field of 3D tissue biology, including culture systems, such as organoids, is emerging as a tool to study the complexities of tissue architecture and function108 in a 3D environment, while allowing perturbations of the system.”
From How to build the virtual cell with artificial intelligence: Priorities and opportunities (2024) · cites this paper as [108]
Citations
Cites
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Self-citationOrganogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Self-citationProspective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Self-citationRegev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232
Self-citationNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C. O., Birney, E., Bodenmiller, B., & Campbell, P. J. (2017) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-162597 · Cited by 1,399
Self-citationCell diversity and network dynamics in photosensitive human brain organoids
Quadrato, G., Nguyen, T., Macosko, E. Z., Sherwood, J. L., Min Yang, S., Berger, D. R., Maria, N., Scholvin, J., Goldman, M., Kinney, J. P., et al. (2017) · Nature · doi:10.1038/nature22047 · Cited by 1,321
Single-cell messenger RNA sequencing reveals rare intestinal cell types
Grün, D., Lyubimova, A., Kester, L., Wiebrands, K., Basak, O., Sasaki, N., Clevers, H., & van Oudenaarden, A. (2015) · Nature · doi:10.1038/nature14966 · Cited by 1,234
Self-citationProgress and potential in organoid research
Rossi, G., Manfrin, A., & Lutolf, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0051-9 · Cited by 1,182
Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
Camp, J. G., Badsha, F., Florio, M., Kanton, S., Gerber, T., Wilsch-Bräuninger, M., Lewitus, E., Sykes, A., Hevers, W., Lancaster, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520760112 · Cited by 1,130
Self-citation
Cited by
Zhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00174-y · Cited by 1,082
Organoid and Spheroid Tumor Models: Techniques and Applications
Gunti, S., Hoke, A. T. K., Vu, K. P., & London, N. R. (2021) · Cancers · doi:10.3390/cancers13040874 · Cited by 479
Next-generation cancer organoids
LeSavage, B. L., Suhar, R. A., Broguiere, N., Lutolf, M. P., & Heilshorn, S. C. (2022) · Nature Materials · doi:10.1038/s41563-021-01057-5 · Cited by 468
Applications of single-cell RNA sequencing in drug discovery and development
Van de Sande, B., Lee, J. S., Mutasa-Gottgens, E., Naughton, B., Bacon, W., Manning, J., Wang, Y., Pollard, J., Mendez, M., Hill, J., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00688-4 · Cited by 437
How to build the virtual cell with artificial intelligence: Priorities and opportunities
Bunne, C., Roohani, Y., Rosen, Y., Gupta, A., Zhang, X., Roed, M., Alexandrov, T., AlQuraishi, M., Brennan, P., Burkhardt, D. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.11.015 · Cited by 393
“Here, the field of 3D tissue biology, including culture systems, such as organoids, is emerging as a tool to study the complexities of tissue architecture and function 108 in a 3D environment, while allowing perturbations of the system.”
Self-citation
Metadata
- Authors
- the Human Cell Atlas ‘Biological Network’ Organoids, Bock, C., Boutros, M., Camp, J. G., Clarke, L., Clevers, H., Knoblich, J. A., Liberali, P., Regev, A., Rios, A. C., Stegle, O., Stunnenberg, H. G., Teichmann, S. A., Treutlein, B., & Vries, R. G. J.
- Affiliations
- Broad Institute (US)
- Austrian Academy of Sciences (AT)
- German Cancer Research Center (DE)
- European Bioinformatics Institute (GB)
- Institute of Molecular Biotechnology (AT)
- Royal Netherlands Academy of Arts and Sciences (NL)
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- ETH Zurich (CH)
- Corresponding author
- Bock, Christoph
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2020-12-31
- Volume
- 39
- Issue
- 1
- Pages
- 13-17
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7801253
- OpenAlex
- W3117494630
- Semantic Scholar
- 77002036736ef3b46470faf2e06e9bf0b2b0668b
- Cited by
- 171
- References
- 16
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 31 · 2023: 31 · 2022: 29 · 2021: 27
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion, other-oa)
- ETH Zürich Research Collection (cc-by)
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Massachusetts Institute of Technology
- Novartis Foundation (16B097)
- Friedrich Miescher Institute for Biomedical Research
- Deutsches Krebsforschungszentrum
- Lahore University of Management Sciences
- Wellcome Trust (104640/Z/14/Z, 104640, 092096)
- European Molecular Biology Laboratory
- Broad Institute
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Cancer Research UK (C13474/A18583, 092096)
- European Commission (874769, 695642, HORIZON2020)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (135715, 31003A)
- Koninklijke Nederlandse Akademie van Wetenschappen
- Österreichischen Akademie der Wissenschaften (SFB F78)
- Austrian Science Fund (SFB F78, F7803‐B)
- Eidgenössische Technische Hochschule Zürich (ETH-17 13-2, ETH-10 15–2)
- Universität Wien
- Medizinische Universität Wien
- Bundesministerium für Bildung, Wissenschaft und Forschung
- Oncode Institute
- Klarman Cell Observatory, Broad Institute
- Functional Genomics Center Zurich
- H2020 European Research Council (693184, 679146)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- human organoids, single-cell technologies, pluripotent cell differentiation, adult stem cells, in vitro disease model, drug testing, regenerative medicine, precision medicine
- MeSH terms
- Atlases as Topic, Humans, Organoids, Databases, Factual, Genome, Computational Biology, Bioengineering, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Organoid Cell Atlas. https://app.cochat.ai/papers/10.1038/s41587-020-00762-x
- The paper
- the Human Cell Atlas ‘Biological Network’ Organoids, Bock, C., Boutros, M., Camp, J. G., Clarke, L., Clevers, H., Knoblich, J. A., Liberali, P., Regev, A., Rios, A. C., Stegle, O., Stunnenberg, H. G., Teichmann, S. A., Treutlein, B., & Vries, R. G. J. (2021). The Organoid Cell Atlas. Nature Biotechnology. https://doi.org/10.1038/s41587-020-00762-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.